Boston Scientific Total Current Liabilities 2010-2024 | BSX

Boston Scientific total current liabilities from 2010 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
  • Boston Scientific total current liabilities for the quarter ending September 30, 2024 were $5.910B, a 29.07% increase year-over-year.
  • Boston Scientific total current liabilities for 2023 were $4.933B, a 29.71% increase from 2022.
  • Boston Scientific total current liabilities for 2022 were $3.803B, a 11.02% decline from 2021.
  • Boston Scientific total current liabilities for 2021 were $4.274B, a 16.11% increase from 2020.
Boston Scientific Annual Total Current Liabilities
(Millions of US $)
2023 $4,933
2022 $3,803
2021 $4,274
2020 $3,681
2019 $4,866
2018 $5,260
2017 $5,654
2016 $3,587
2015 $2,430
2014 $2,846
2013 $1,824
2012 $1,772
2011 $1,807
2010 $2,609
2009 $3,022
Boston Scientific Quarterly Total Current Liabilities
(Millions of US $)
2024-09-30 $5,910
2024-06-30 $5,576
2024-03-31 $4,916
2023-12-31 $4,933
2023-09-30 $4,579
2023-06-30 $4,562
2023-03-31 $4,083
2022-12-31 $3,803
2022-09-30 $3,549
2022-06-30 $3,883
2022-03-31 $4,275
2021-12-31 $4,274
2021-09-30 $4,022
2021-06-30 $4,073
2021-03-31 $3,393
2020-12-31 $3,681
2020-09-30 $3,302
2020-06-30 $3,108
2020-03-31 $3,976
2019-12-31 $4,866
2019-09-30 $4,254
2019-06-30 $4,850
2019-03-31 $4,479
2018-12-31 $5,260
2018-09-30 $5,082
2018-06-30 $4,753
2018-03-31 $4,988
2017-12-31 $5,654
2017-09-30 $4,828
2017-06-30 $4,300
2017-03-31 $3,490
2016-12-31 $3,587
2016-09-30 $3,016
2016-06-30 $3,182
2016-03-31 $2,608
2015-12-31 $2,430
2015-09-30 $2,238
2015-06-30 $1,937
2015-03-31 $2,463
2014-12-31 $2,846
2014-09-30 $1,820
2014-06-30 $1,773
2014-03-31 $1,719
2013-12-31 $1,824
2013-09-30 $1,902
2013-06-30 $2,477
2013-03-31 $1,636
2012-12-31 $1,772
2012-09-30 $1,815
2012-06-30 $1,794
2012-03-31 $1,669
2011-12-31 $1,807
2011-09-30 $1,887
2011-06-30 $1,892
2011-03-31 $2,040
2010-12-31 $2,609
2010-09-30 $2,955
2010-06-30 $3,723
2010-03-31 $2,913
2009-12-31 $3,022
2009-09-30 $3,176
2009-06-30 $2,750
2009-03-31 $2,431
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $134.855B $14.240B
Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $203.382B 25.94
Stryker (SYK) United States $148.728B 33.52
EssilorLuxottica (ESLOY) France $111.549B 0.00
Medtronic (MDT) Ireland $108.676B 16.14
Haleon (HLN) United Kingdom $43.230B 28.09
Lonza Group Ag (LZAGY) Switzerland $42.368B 0.00
GE HealthCare Technologies (GEHC) United States $37.464B 19.43
ResMed (RMD) United States $35.759B 29.39
Terumo (TRUMY) Japan $29.367B 41.47
Koninklijke Philips (PHG) Netherlands $24.796B 18.98
Zimmer Biomet Holdings (ZBH) United States $21.580B 13.74
Insulet (PODD) United States $18.378B 73.18
Baxter (BAX) United States $16.844B 10.96
Smith & Nephew SNATS (SNN) United Kingdom $10.947B 0.00
BellRing Brands (BRBR) United States $9.886B 39.63
Bio-Rad Laboratories (BIO) United States $9.115B 30.98
Demant (WILYY) Denmark $8.342B 0.00
Lantheus Holdings (LNTH) United States $6.071B 14.11
TG Therapeutics (TGTX) United States $5.378B 0.00
Haemonetics (HAE) United States $4.291B 20.94
Prestige Consumer Healthcare (PBH) United States $4.157B 20.67
ICU Medical (ICUI) United States $4.134B 39.36
Perrigo (PRGO) Ireland $3.694B 10.88
Envista Holdings (NVST) United States $3.681B 27.42
Agios Pharmaceuticals (AGIO) United States $3.167B 0.00
Neogen (NEOG) United States $3.159B 36.45
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.782B 17.84
QuidelOrtho (QDEL) United States $2.548B 16.40
LeMaitre Vascular (LMAT) United States $2.380B 57.85
Warby Parker (WRBY) United States $2.366B 0.00
Green Thumb Industries (GTBIF) United States $1.977B 34.59
AtriCure (ATRC) United States $1.740B 0.00
InMode (INMD) Israel $1.552B 9.34
AdaptHealth (AHCO) United States $1.331B 9.51
Curaleaf Holdings (CURLF) Canada $1.293B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.253B 0.00
BioLife Solutions (BLFS) United States $1.178B 0.00
Phibro Animal Health (PAHC) United States $0.962B 16.97
Owens & Minor (OMI) United States $0.943B 7.37
National Vision Holdings (EYE) United States $0.910B 30.40
CeriBell (CBLL) United States $0.904B 0.00
Evolus (EOLS) United States $0.826B 0.00
Capricor Therapeutics (CAPR) United States $0.809B 0.00
VAREX IMAGING (VREX) United States $0.679B 30.02
Surmodics (SRDX) United States $0.561B 0.00
Cresco Labs (CRLBF) United States $0.561B 0.00
Verano Holdings (VRNOF) United States $0.554B 0.00
Quanterix (QTRX) United States $0.450B 0.00
Omeros (OMER) United States $0.448B 0.00
Canopy Growth (CGC) Canada $0.407B 0.00
ZimVie (ZIMV) United States $0.379B 31.95
Valneva SE (VALN) France $0.359B 0.00
Viemed Healthcare (VMD) United States $0.339B 32.26
Biote (BTMD) United States $0.334B 7.31
Sanara MedTech (SMTI) United States $0.326B 0.00
Cerus (CERS) United States $0.310B 0.00
OraSure Technologies (OSUR) United States $0.287B 19.25
Zynex (ZYXI) United States $0.258B 54.07
Aurora Cannabis (ACB) Canada $0.236B 0.00
TerrAscend (TSNDF) Canada $0.224B 0.00
Utah Medical Products (UTMD) United States $0.219B 15.12
High Tide (HITI) Canada $0.215B 89.00
MacroGenics (MGNX) United States $0.201B 0.00
Sanuwave Health (SNWV) United States $0.189B 2.67
Jin Medical (ZJYL) China $0.166B 0.00
Organigram Holdings (OGI) Canada $0.164B 0.00
Brainsway (BWAY) Israel $0.164B 98.40
Zevia PBC (ZVIA) United States $0.150B 0.00
FitLife Brands (FTLF) United States $0.147B 18.50
TriSalus Life Sciences (TLSI) United States $0.135B 0.00
Fonar (FONR) United States $0.104B 11.75
Quipt Home Medical (QIPT) United States $0.102B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 23.10
Veru (VERU) United States $0.092B 0.00
Ayr Wellness (AYRWF) United States $0.079B 0.00
Rockwell Medical (RMTI) United States $0.071B 36.67
Exagen (XGN) United States $0.069B 0.00
Modular Medical (MODD) United States $0.067B 0.00
Cellectar Biosciences (CLRB) United States $0.065B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
InterCure (INCR) Israel $0.061B 0.00
MariMed (MRMD) United States $0.059B 0.00
Safety Shot (SHOT) United States $0.053B 0.00
Apyx Medical (APYX) United States $0.053B 0.00
Cytosorbents (CTSO) United States $0.049B 0.00
Allurion Technologies (ALUR) United States $0.033B 0.00
ImmuCell (ICCC) United States $0.033B 0.00
Flora Growth (FLGC) United States $0.018B 0.00
Meihua Medical Technologies (MHUA) China $0.017B 0.00
Innovative Eyewear (LUCY) United States $0.016B 0.00
Nephros (NEPH) United States $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Senestech (SNES) United States $0.002B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.83
SNDL (SNDL) Canada $0.000B 0.00